Phase 3 cardiovascular outcomes study with olpasiran (OCEAN(a)-Outcomes, NCT05581303, Ongoing)
Download slides >>
Educational Partners and Supporters
AstraZeneca has provided a sponsorship grant towards this independent programme.
